| First Author | Ishikawa K | Year | 2016 |
| Journal | Am J Pathol | Volume | 186 |
| Issue | 4 | Pages | 859-73 |
| PubMed ID | 26878210 | Mgi Jnum | J:231525 |
| Mgi Id | MGI:5771715 | Doi | 10.1016/j.ajpath.2015.11.014 |
| Citation | Ishikawa K, et al. (2016) alphaB-Crystallin Regulates Subretinal Fibrosis by Modulation of Epithelial-Mesenchymal Transition. Am J Pathol 186(4):859-73 |
| abstractText | Subretinal fibrosis is an end stage of neovascular age-related macular degeneration, characterized by fibrous membrane formation after choroidal neovascularization. An initial step of the pathogenesis is an epithelial-mesenchymal transition (EMT) of retinal pigment epithelium cells. alphaB-crystallin plays multiple roles in age-related macular degeneration, including cytoprotection and angiogenesis. However, the role of alphaB-crystallin in subretinal EMT and fibrosis is unknown. Herein, we showed attenuation of subretinal fibrosis after regression of laser-induced choroidal neovascularization and a decrease in mesenchymal retinal pigment epithelium cells in alphaB-crystallin knockout mice compared with wild-type mice. alphaB-crystallin was prominently expressed in subretinal fibrotic lesions in mice. In vitro, overexpression of alphaB-crystallin induced EMT, whereas suppression of alphaB-crystallin induced a mesenchymal-epithelial transition. Transforming growth factor-beta2-induced EMT was further enhanced by overexpression of alphaB-crystallin but was inhibited by suppression of alphaB-crystallin. Silencing of alphaB-crystallin inhibited multiple fibrotic processes, including cell proliferation, migration, and fibronectin production. Bone morphogenetic protein 4 up-regulated alphaB-crystallin, and its EMT induction was inhibited by knockdown of alphaB-crystallin. Furthermore, inhibition of alphaB-crystallin enhanced monotetraubiquitination of SMAD4, which can impair its nuclear localization. Overexpression of alphaB-crystallin enhanced nuclear translocation and accumulation of SMAD4 and SMAD5. Thus, alphaB-crystallin is an important regulator of EMT, acting as a molecular chaperone for SMAD4 and as its potential therapeutic target for preventing subretinal fibrosis development in neovascular age-related macular degeneration. |
